Table IV.
A, Upregulated | |||
---|---|---|---|
Gene | Gene name | Log2 fold change | P-value |
ENSG00000278233 | RNA5-8S5 | Inf | 6.06×10−76 |
ENSG00000173641 | HSPB7 | 2.385567771 | 1.16×10−15 |
ENSG00000211448 | DIO2 | 2.673293409 | 1.29×10−13 |
ENSG00000180914 | OXTR | 2.819903839 | 3.15×10−13 |
ENSG00000278637 | HIST1H4A | 3.414824971 | 3.65×10−13 |
B, Downregulated | |||
Gene | Gene name | Log2 fold change | P-value |
ENSG00000070669 | ASNS | −2.324211247 | 8.79×10−19 |
ENSG00000101255 | TRIB3 | −3.045732779 | 4.70×10−18 |
ENSG00000101670 | LIPG | −4.329305637 | 5.84×10−17 |
ENSG00000151012 | SLC7A11 | −2.303459954 | 1.21×10−15 |
ENSG00000128965 | CHAC1 | −2.868385986 | 1.51×10−14 |
‘Inf’ indicates the expression level in the Day 0 group was 0; compared with that in the Day 0 group, the expression in the Day 7 group was greatly upregulated. P-values from low to high were used as the selection criteria.